Table 1 Patient clinical characteristics and detection level of F. nucleatum
From: Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma
Clinical Characteristic | Total Number of Patients | Total Detect Number | Samples for detect F. nucleatum (N = 98) | ||
|---|---|---|---|---|---|
Positive | Negative | P-value | |||
111 | 98 | 68(69.4%) | 30(29.6%) | ||
Age (mean, range) | |||||
62.9 ± 7.1 | |||||
  < 60 | 31(27.9%) | 29 | 22(75.9%) | 7(24.1%) | 0.1412 |
  > 60 | 80(72.7%) | 69 | 46(66.7%) | 23(33.3%) |  |
Gender | |||||
 Male | 64(57.7%) | 56 | 39(69.6%) | 17(30.4%) | 0.9989 |
 Female | 47(42.3%) | 42 | 29(69%) | 13(31%) |  |
Smoking | |||||
 Yes | 44(39.6%) | 39 | 26(66.7%) | 13(33.3%) | 0.9428 |
 No | 67(60.4%) | 59 | 42(71.2%) | 17(28.8%) |  |
Drinking | |||||
 Yes | 46(41.4%) | 39 | 25(64.1%) | 14(35.9%) | 0.5561 |
 No | 65(58.6%) | 59 | 43(72.9%) | 16(28.8%) |  |
Histopathological grading | |||||
 G1–2 | 79(71.2%) | 72 | 50(69.4%) | 22(30.6%) | 0.5305 |
 G3 | 32(28.8%) | 26 | 18(69.2%) | 8(30.8%) |  |
clinical T stage (pT) | |||||
 pT1–2 | 44(39.6%) | 35 | 24(68.6%) | 11(31.4%) | 0.039 |
 pT3–4 | 67(60.4%) | 63 | 44(69.8%) | 19(30.2%) |  |
lymph node | |||||
 pN0–1 | 97(87.4%) | 89 | 61(68.5%) | 28(31.5%) | 0.1343 |
 pN2–3 | 14(12.6%) | 9 | 7(77.8%) | 2(22.2%) |  |
Clinical tumor stage | |||||
 I | 8(7.2%) | 4 | 3(75%) | 1(25%) | 0.0033 |
 II | 71(64%) | 68 | 44(64.7%) | 24(35.3%) |  |
 III | 32(28.8%) | 26 | 21(84%) | 5(15.4%) |  |